Arkolith/Insider Trading/RPRX/Form 4

Norden Gregory

DirectorRoyalty Pharma plc (RPRX) · full profile →Form 4 · filed May 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$161K
Net Open-Market Flow
-$161K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2026Sell(S)3K$53.00$161K192K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001405104-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML